How the Use of non-Registrational Evidence by Medical Affairs Improves Patient Outcomes
This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.
Moving Beyond Ad Boards: Asynchronous HCP Engagement Strategies
This podcast, sponsored by Impetus Digital, explores the opportunities and benefits of platforms that deliver asynchronous engagement, noting dramatic increases in HCP/KOL participation and cost-per-word.
How Can Medical Affairs Maximize Strategic Impact within the Organization?
This webinar explores MA’s future in healthcare innovation and leadership as part of the development of cross-functional goals to help achieve patient benefits.
Surprising Lessons for Medical Presenters from the Acropolis
Near the end of Jill Donahue’s family trip to Greece, an unlicensed tour guide, Charis, showed what communication mastery looks like.
Field Medical External Stakeholders: Episode 1 – Medical Communication Agencies
This MAPS podcast details potential areas for compliant collaboration by MSLs with key external partners.
How MyHealthTeams Cofounder and CEO, Eric Peacock, Brings a Patient-Centric Perspective to Medical Affairs
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
The Art and Science of Journal Selection
This paper addresses the complexities of prioritizing contemporary journal offerings to accomplish article objectives and overall publication planning goals.
3 Ways Medical Affairs Leaders can Start Using Social Media Insights Now
In this webinar, experts share real-life examples of how Medical Affairs can use social media insights to improve outcomes for customers and patients.
The Evolving use of Social Media in Medical Affairs
This podcast sponsored by IQVIA explores social media for insights and thought leader identification.
Health Disparities 1: FDA Efforts to Advance Women and Minorities in Clinical Trials
This session provides a learning opportunity for our audience by providing background on FDA’s Offices of Minority Health and Health Equity, and Women’s Health